Diagnosis Clinical Trial
Official title:
Dual Tracer Functional Imaging of Nonfunctional Pancreatic Neuroendocrine Tumors Using 68Ga-DOTA-NOC and 18F-FDG PET/CT
Predicting aggressive behavior in the group of nonfunctional pancreatic neuroendocrine
tumors (NF P-NET) remains a difficult problem in clinical practice. At present, the
treatment planning in P-NET is significantly restricted by the limited results of
conventional imaging. In addition, increasing use of multidetector computed tomography
(MDCT) and magnetic resonance imaging (MRI) is increasing the number of NF P-NETs detected.
Somatostatin receptor scintigraphy (SRS) combined with anatomical imaging are the
conventional modalities in imaging of P-NET, but by these methods the diagnostic accuracy
still remains compromised. Furthermore, recently encouraging results have been obtained in
P-NET using 68Ga-labelled somatostatin analog, DOTA-1-NaI3-octreotide (68Ga-DOTANOC)
positron emission tomography-computed tomography (PET-CT).
The aim of the current project is to evaluate the possibility to enhance the diagnostic
accuracy by using dual trace functional imaging 18F-labelled fluorodeoxyglucose (18F-FDG)
and 68Ga-DOTANOC PET-CT imaging in patients with NF P-NET. The study consists of 20 patients
with NF P-NET. The patients enrolled in the study will be imaged 68Ga-DOTANOC and 18F-FDG
PET-CT followed by surgery or follow-up with endoscopic ultrasonography (EUS) biopsies. The
data will be collected between autumn 2015 and spring 2018.
n/a
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05845112 -
Start Taking Action For TB Diagnosis
|
||
| Not yet recruiting |
NCT05889312 -
Assessing Cancer Treatment Response to Therapy Using 18F-FSPG PET
|
||
| Completed |
NCT01194557 -
Introducing Rapid Diagnostic Tests Into the Private Health Sector
|
N/A | |
| Completed |
NCT04257955 -
COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncer
|
||
| Recruiting |
NCT05698212 -
Proof of Concept Study to Eval MetriDx Lab-developed Test to Identify Endometriosis-specific Bio Markers
|
Phase 2 | |
| Recruiting |
NCT03372330 -
Peripheral Artery Disease and Sepsis Outcomes
|
N/A | |
| Active, not recruiting |
NCT06134011 -
A Multi-omics-based Metabolic Typing Study of Gastric Cancer
|
||
| Recruiting |
NCT06289803 -
The Application of Probe Confocal Laser Endomicroscopy in Pancreatic Tumor Surgery
|
N/A | |
| Not yet recruiting |
NCT06025240 -
Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients
|
||
| Not yet recruiting |
NCT05464576 -
Tumor Staging T of Bladder Tumours: Correlation of MRI and Anatomopathologic Analysis
|
N/A | |
| Completed |
NCT06185127 -
Dexmedetomidine-ketamine Combination Versus Fentanyl-midazolam During Bronchoscopy
|
Phase 3 | |
| Recruiting |
NCT05824442 -
Evaluation of a New Multiplex Quantitative PCR Technique for the Diagnosis of Echinococcosis
|
N/A | |
| Not yet recruiting |
NCT06463223 -
HIBOC = Hepatic Imaging Biomarkers in Obese Children
|
||
| Not yet recruiting |
NCT06072820 -
Analytical Evaluation of the Endotest® Diagnostic
|
N/A | |
| Recruiting |
NCT05587114 -
Comparision of Various Biomarkers Between Peripheral and Pulmonary Blood
|
||
| Recruiting |
NCT06230458 -
Fractional Exhaled Nitric Oxide (FeNO)- Test as add-on Test in the Diagnostic Work-up of Asthma
|
N/A | |
| Not yet recruiting |
NCT05947565 -
Patient Position and Invasive Urodynamic Study Results in Males
|
N/A | |
| Not yet recruiting |
NCT05948410 -
How Does the Mood of the Patients Change Before and After the Invasive Urodynamic Study?
|
||
| Not yet recruiting |
NCT04490746 -
Identifcation of Biomarkers for Active Pulmonary Tuberculosis
|
||
| Completed |
NCT03381131 -
Chinese Version of Fibromyalgia Criteria and Severity Scales Study
|